JDRF Blog

JDRF Blog

Information on research, events, activities, and news from the T1D community across Canada. 

Subscribe to the newsletter

Monsters are real

JDRF Canada has a plan to defeat the T1D monster that burdens 300,000 Canadians.

Read More

Tannis M. Richardson: T1D Champion Gives Back to the Community

Tannis M. Richardson: T1D Champion Gives Back to the Community

Giving back to others has been a way of life since Tannis was a young girl growing up in Winnipeg. Her parents were always community-minded, with hersurgeon father establishing the first collective medical facility, the Winnipeg Clinic, and her mother lending support to various organizatio...


#AccessForAll in the age of COVID-19

#AccessForAll in the age of COVID-19

As COVID-19 continues to dominate global headlines, the journey to #AccessForAll remains.


Talking to an expert on T1D and COVID-19

Talking to an expert on T1D and COVID-19

A Q & A with Dr. Rémi Rabasa-Lhoret, JDRF-funded clinical scientist and endocrinologist at the Institut de recherches cliniques de Montréal


Landmark trial of T1D-related kidney disease misses primary outcome, but provides valuable lessons

Landmark trial of T1D-related kidney disease misses primary outcome, but provides valuable lessons

Kidney disease remains one of the leading complications of diabetes, including the need for dialysis or kidney transplant. This led to the Preventing Early Renal Loss in Diabetes (PERL) trial, a joint initiative between investigators across North America and Denmark.


Using your voice to fight against type 1 diabetes

Using your voice to fight against type 1 diabetes

At JDRF, we know that when it comes to fighting against type 1 diabetes (T1D), there is strength in numbers.


Ask the Pediatrician: T1D and COVID-19

Ask the Pediatrician: T1D and COVID-19

A Q & A with Dr. Farid Mahmud, JDRF-funded pediatric endocrinologist at The Hospital for Sick Children in Toronto.


Nurse with T1D is reminded of her resilience after surviving COVID-19

Nurse with T1D is reminded of her resilience after surviving COVID-19

When Sarah Ayers and her boyfriend returned from a trip to Europe in early March, talk of an impending pandemic in Canada was flooding the media and travelers were being advised to self-isolate as a precaution


Updates from the Teplizumab Trial: You're Not Going to Believe the Results

Updates from the Teplizumab Trial: You're Not Going to Believe the Results

Last year, at the American Association for Diabetes (ADA) Scientific Sessions, a drug, called teplizumab, was able to significantly delay—for over two years—the onset of type 1 diabetes (T1D) in participants with a high risk of developing the disease. This was the first ever st...


"Without my cousin's discovery, I wouldn't be alive today"

"Without my cousin's discovery, I wouldn't be alive today"

My name is Rebecca Redmond, and I am #MoreThanT1D. I’m a writer, a public speaker, a mom, a wife, a sister, a daughter, a friend…and Sir Frederick Banting’s cousin.


Advocacy in a post-Covid-19 world

Advocacy in a post-Covid-19 world

Your stories make all the difference.


Lets turn type one into type none